JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M512073200 on March 27, 2006

J. Biol. Chem., Vol. 281, Issue 21, 14622-14631, May 26, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/21/14622    most recent
M512073200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Williams, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Williams, D. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Functions of ERp57 in the Folding and Assembly of Major Histocompatibility Complex Class I Molecules*

Yinan Zhang{ddagger}, Ehtesham Baig§, and David B. Williams{ddagger}§1

From the Departments of {ddagger}Biochemistry and §Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada

Received for publication, November 9, 2005 , and in revised form, March 3, 2006.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
ERp57 is a thiol oxidoreductase of the endoplasmic reticulum that appears to be recruited to substrates indirectly through its association with the molecular chaperones calnexin and calreticulin. However, its functions in living cells have been difficult to demonstrate. During the biogenesis of class I histocompatibility molecules, ERp57 has been detected in association with free class I heavy chains and, at a later stage, with a large complex termed the peptide loading complex. This implicates ERp57 in heavy chain disulfide formation, isomerization, or reduction as well as in the loading of peptides onto class I molecules. In this study, we show that ERp57 does indeed participate in oxidative folding of the heavy chain. Depletion of ERp57 by RNA interference delayed heavy chain disulfide bond formation, slowed folding of the heavy chain {alpha}3 domain, and caused slight delays in the transport of class I molecules from the endoplasmic reticulum to the Golgi apparatus. In contrast, heavy chain-beta2-microglobulin association kinetics were normal, suggesting that the interaction between heavy chain and beta2 -microglobulin does not depend on an oxidized {alpha}3 domain. Likewise, the peptide loading complex assembled properly, and peptide loading appeared normal upon depletion of ERp57. These studies demonstrate that ERp57 is involved in disulfide formation in vivo but do not support a role for ERp57 in peptide loading of class I molecules. Interestingly, depletion of another thiol oxidoreductase, ERp72, had no detectable effect on class I biogenesis, consistent with a specialized role for ERp57 in this process.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Protein folding within the endoplasmic reticulum (ER)2 is assisted by a diverse array of folding catalysts and molecular chaperones. Folding catalysts include as many as 17 members of the protein-disulfide isomerase (PDI) family of proteins as well as peptidylprolyl cis-trans isomerases. ERp57 (13) is a member of the PDI family and contains four thioredoxin domains with two CXXC active sites located within the first and fourth domains (4, 5). Like PDI (6, 7), ERp57 has been shown to catalyze disulfide oxidation, isomerization, and reduction in vitro (810). However, it is distinct from other PDI family members in that it associates noncovalently with the molecular chaperones calnexin (CNX) and calreticulin (CRT) (11). These chaperones bind preferentially to nonnative glycoproteins bearing monoglucosylated Glc1Man5–9-GlcNAc2 oligosaccharides (12, 13). It is thought that the ternary complex of ERp57, CNX/CRT, and unfolded glycoprotein enhances the rate of disulfide formation/isomerization by keeping the enzyme in proximity to the substrate. Consistent with this view, the activity of ERp57 toward monoglucosylated glycoprotein substrates is dramatically enhanced in vitro when CNX or CRT is present (10). Furthermore, ERp57 forms mixed disulfide intermediates with model viral glycoproteins in vivo, and these complexes are abrogated when the formation of monoglucosylated oligosaccharides is blocked (14). Despite these suggestive findings, there is little evidence that ERp57 actually promotes oxidative folding of any protein in living cells.

To address the functions of ERp57 in cells, we have been studying the biogenesis of class I molecules of the major histocompatibility complex (MHC), a system in which interactions with ERp57 are well established. Class I molecules bind to cytosolically derived peptide antigens and subsequently display them at the cell surface, where they are screened by cytotoxic T cells. They consist of a glycosylated transmembrane heavy chain (H chain) with three extracellular domains termed {alpha}1, {alpha}2, and {alpha}3, a soluble subunit termed beta2-microglobulin (beta2m), and a peptide ligand of 8–10 residues. Assembly of class I molecules begins within the ER, where the nascent H chain binds to the membrane-bound chaperone CNX and, indirectly, to ERp57 (15, 16). At this early stage, H chain disulfide bond formation takes place, although the order of formation of the two disulfides within the {alpha}2 and {alpha}3 domains remains unclear (17). The efficiency of complete disulfide formation is substantially increased upon H chain association with beta2m (17, 18). Correct disulfide bond formation is crucial, since mutagenesis of cysteines comprising either disulfide results in reduced cell surface expression and defects in peptide loading (19, 20). Once H chain associates with beta2m, a peptide loading complex assembles that consists of the class I heterodimer, CNX, or its soluble paralog CRT, ERp57, Bap31, the TAP peptide transporter, and another protein, tapasin. The peptides that bind to class I are primarily generated in the cytosol by the proteasome and are transported into the ER by the TAP transporter. Tapasin serves as a bridge between class I and TAP (21, 22), thereby placing class I molecules close to the peptide source. In addition, tapasin stabilizes the peptide loading complexes and enhances the loading of high affinity peptides into the class I binding groove (23, 24). Upon peptide binding to class I, the loading complex dissociates, thereby permitting fully assembled class I molecules to be exported from the ER to the cell surface, a process that is facilitated in the ER by Bap31 (25).

Relative to other members of the PDI family, ERp57 appears to enjoy a privileged position in class I biogenesis. ERp57, but not PDI, has been detected in association with both free and beta2m-associated H chains and as a component of the peptide loading complex (8, 26, 27). Furthermore, Cresswell and co-workers have demonstrated that between 15 and 80% of the total ERp57 pool can be associated with class I peptide loading complexes and that ERp57 is present exclusively in disulfide linkage to tapasin (28). The introduction of cysteine mutants in tapasin not only abolishes the formation of the ERp57-tapasin complex but also prevents full oxidation of the class I H chain and impairs the loading of high affinity peptides (29). Whether these phenotypes are due to the lack of ERp57 or a secondary consequence of the tapasin mutations remains to be determined. These studies have led to suggestions that ERp57 may participate in the oxidative folding of the class I H chain, and, together with tapasin, may make class I molecules more receptive to peptide loading through isomerization of the disulfide bond within the peptide binding groove.

In this study, we used RNA interference to reduce the expression of ERp57 as a means to assess its functions in class I biogenesis. We show that in the absence of ERp57, H chain disulfide bond formation and {alpha}3 domain folding are substantially delayed, whereas the rate of ER to Golgi transport is slowed only slightly. No effect of ERp57 depletion was observed on the kinetics of H chain-beta2m association, assembly of the peptide loading complex, or the loading of peptides onto class I. These findings support a role for ERp57 in H chain disulfide formation but suggest that the ERp57-tapasin disulfide conjugate may not be required for peptide loading. Interestingly, reducing the expression of another ER thiol oxidoreductase, ERp72, was completely without effect on class I biogenesis, consistent with a specialized role for ERp57 in this process and the existence of substrate preferences among different thiol oxidoreductases.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cells and Antibodies—Mouse L cells stably expressing the class I molecules, H-2Kb or H-2Dd, were maintained in high glucose DMEM supplemented with 10% fetal bovine serum, glutamine, and antibiotics. Mouse EL4 cells expressing a truncated version of ovalbumin (residues 253–386; a kind gift of Dr. N. Shastri, University of California Berkeley) were cultured in RPMI 1640 supplemented with 10% fetal bovine serum, glutamine, and antibiotics. The following antibodies (Abs) were used in this study: anti-8, a rabbit polyclonal antiserum, which recognizes the carboxyl terminus of the Kb molecule encoded by exon-8 (30); monoclonal antibody (mAb) 34-2-12S, which recognizes the folded{alpha}3 domain of Dd molecules with an intact disulfide bond (17, 31); mAb 34-5-8S, specific for beta2m-associated Dd molecules (31); mAbs Y3 and 20-8-4S, which recognize beta2m-associated Kb molecules (32, 33); and mAb 25-D1-16, which is specific for Kb molecules complexed with the ovalbumin-derived peptide SIINFEKL (34). Rabbit anti-tapasin antiserum directed against the carboxyl-terminal 20 amino acids of murine tapasin and anti-CNX antiserum raised against the ER luminal domain of dog CNX have been described previously (35, 36). Anti-ERp57 antiserum was raised against glutathione S-transferase-fused mouse ERp57. The anti-glutathione S-transferase antibodies were removed by adsorption to glutathione S-transferase-agarose prior to use. Anti-CRT antiserum (SPA-600), anti-ERp72 antiserum (SPA-720), and anti-PDI antiserum (SPA-891) were purchased from StressGen Biotechnologies (Victoria, Canada). Rabbit anti-actin antiserum was purchased from Sigma. Anti-CaBP1 antiserum was the generous gift of Dr. D. Ferrari (Max Planck Institute for Biophysical Chemistry, Goettingen, Germany).

RNA Interference and Transfections—Two double-stranded small interfering RNAs (siRNAs) corresponding to mouse ERp57 DNA sequences AGCCAGCAACTTGAGAGATAA (siRNA 1) and AAGAGGCTTGCCCCTGAGTAT (siRNA 2) were synthesized and annealed by Qiagen (Valencia, CA). siRNA 2 was fluorescein isothiocyanate-labeled to facilitate measurement of transfection efficiency. siRNA targeting mouse ERp72 (AAGCAGTTTGCTCCAGAATAT) and nontargeting control siRNA (AATTCTCCGAACGTGTCACGT) were also purchased from Qiagen. Eighteen hours before transfection, 1 x 105 mouse L cells expressing H-2Kb or H-2Dd were seeded into 6-well dishes. siRNAs were transfected into the cells using oligofectamine (Invitrogen) according to the manufacturer's protocol with a final siRNA concentration of 40 nM. Cells were transfected for 4 days before assays were performed. For mouse EL4 TO cells, ERp57 siRNA was premixed with solution T included in the Nucleofector kit T (final siRNA concentration of 240 nM), and 6 x 105 cells were transfected with the Nucleofector device using parameter O17 (Amaxa GmbH, Cologne, Germany). Cells were maintained in RPMI 1640 in the presence of siRNA for 3 days before being assessed for surface expression of Kb-SIINFEKL peptide complexes. For all RNA interference experiments, ~1 x 105 siRNA-transfected cells were used to assess the efficiency of protein knockdown by Western blot. Cell lysates were separated by SDS-PAGE, transferred onto an Immobilon membrane (Millipore Corp., Bedford, MA), and probed with the appropriate antiserum. Detection was performed by ECL (Amersham Biosciences).

Metabolic Radiolabeling and Immunoisolation—Pulse-chase radiolabeling experiments with siRNA-transfected L cells expressing either Kb or Dd molecules were performed in 35-mm plates. Cells were starved for 30 min with methionine-free RPMI 1640 and pulse-labeled for 2 min with 0.5 ml of medium containing 0.1 mCi of [35S]Met (>1000 Ci/mmol; Amersham Biosciences). Cells were then washed with Met-free RPMI 1640 and chased for various periods in DMEM containing 1 mM Met and 500 µM cycloheximide. After washing for 3 min in cold PBS containing 20 mM N-ethylmaleimide (NEM), lysis was conducted in 500 µl of PBS, pH 6.8, containing 1% Nonidet P-40, 20 mM NEM, and protease inhibitors (60 µg/ml 2-aminoethyl-benzenesulfonylfluoride and 10 µg/ml each leupeptin, antipain, and pepstatin (BioShop, Burlington, Canada)). Following centrifugation at 10,000 x g to remove nuclei and cell debris, the supernatant fraction was incubated on ice for 2 h with either anti-8 or 20-8-4S Ab for Kb and either 34-2-12S or 34-5-8S Ab for Dd. Immune complexes were recovered by shaking for 1 h with 30 µl of packed protein A-agarose beads. Proteins were eluted with SDS-PAGE sample buffer from the beads and analyzed either by nonreducing or reducing SDS-PAGE (10% gel) followed by fluorography. Films were scanned using an EPSON 1680 scanner and were quantified using NIH Image software (National Institutes of Health). In all cases, backgrounds were subtracted by quantifying a blank area of the film corresponding in size to that of the gel band of interest.

In experiments to assess the formation of the peptide loading complex, cells were radiolabeled for 45 min with [35S]Met, washed in cold PBS containing 20 mM NEM, and lysed in digitonin lysis buffer (1% digitonin in PBS, pH 6.8, 20 mM N-ethylmaleimide, and protease inhibitors). The lysate was incubated with anti-tapasin antiserum for 2 h. Immune complexes were recovered with protein A-agarose and then washed twice with 0.2% digitonin in PBS, pH 6.8, before elution and analysis by SDS-PAGE.

For class I ER to Golgi transport assays, Kb and Dd molecules were immunoisolated with anti-8 and 34-2-12S Ab, respectively, as described above and then were eluted from protein A beads with 0.1 M citrate buffer, pH 6, containing 0.1% SDS and digested with 2 units of endo-beta-N-acetylglucosaminidase H (endo H; New England Biolabs, Beverly, MA) at 37 °C for 2 h prior to analysis by SDS-PAGE.

Flow Cytometry Analysis—To assess the cell surface levels of class I molecules, 3–5 x 105 cells were trypsinized from culture dishes and incubated with mouse anti-class I mAbs (1.5 µg of mAb Y3 for Kb or mAb 34-5-8S for Dd) in 100 µl of culture medium for 20 min on ice. After incubation, cells were washed once with fluorescence-activated cell sorting buffer (Hanks' balanced salt solution, 1% bovine serum albumin, and 0.01% NaN3) and then incubated with 0.4 µg of phycoerythrin-conjugated goat anti-mouse IgG (H+L chain-specific, Cedarlane, Hornby, Canada) in 100 µl of fluorescence-activated cell sorting buffer for 20 min on ice. Cells were washed twice with fluorescence-activated cell sorting buffer and then fixed in 0.5% paraformaldehyde in PBS, pH 7.4. Subsequent flow cytometry was performed using an EPICS Elite flow cytometer (Beckman Coulter, Fullerton, CA).

For analysis of the turnover kinetics of cell surface class I molecules, Kb -or Dd-expressing L cells were incubated for 18 h at 26 °C in DMEM containing 10 µg/ml human beta2m (Sigma). Human beta2m-containing DMEM was then replaced with prewarmed DMEM containing 10 µg/ml brefeldin A (Sigma), and cells were transferred to a 37 °C incubator. Cells (3–5 x 105) were removed at the indicated time points and analyzed by flow cytometry as described above.

Kb-SIINFEKL complexes on the surface of EL4 TO cells were measured by flow cytometry using mAb 25-D1-16. The SIINFEKL peptide loading efficiency was expressed as the Kb-SIINFEKL level divided by the surface Kb level (as detected with mAb Y3).

Quantification of Interferon {alpha} and beta mRNAs—L cells expressing Kb molecules were either untransfected or transfected with control siRNA, siRNA targeting ERp57, and siRNA targeting ERp72. Cells were harvested after 12 h, and total RNA was extracted with the RNeasy Mini Kit (Qiagen). Digestion of contaminating DNA was performed using Fermentas DNaseI according to the manufacturer's protocol. cDNA was synthesized using 1 µg of RNA in the presence of random primers and Moloney murine leukemia virus reverse transcriptase (Invitrogen) according to the manufacturer's protocol.

For quantitative PCR, reaction components were obtained from the LightCycler® FastStart DNA Master SYBR GreenPLUS I kit (Roche Applied Science). The LightCycler® instrument (Roche Applied Science) and corresponding software was used for all reactions. The following reaction conditions were used: preincubation at 95 °C for 10 min, followed by 45 amplification cycles of 95 °C for 10 s, 60 °C for interferon (IFN)-beta, 65 °C for IFN-{alpha}2, and 60 °C for hypoxanthine-guanine phosphoribosyltransferase (HPRT) for 5 s, 72 °C for 10 s, melting curve analysis at 95 °C for 0 s, 65 °C for 15 s, and a continuous acquisition mode of 95 °C with a temperature transition rate of 0.1 °C/s. The PCR was performed in a final volume of 20 µl containing 1x Master SYBR GreenPLUS I buffer, 20 pmol of HPRT and IFN-beta primers, 10 pmol of IFN-{alpha}2 primers, and 5 µl of template cDNA (concentration 100 ng/µl). The following primer sets were used: for IFN-{alpha}2, 5'-AAAGGGGAGCCTCCTCAT-3' (forward) and 5'-TGCTTTCCTCGTGATGCTGA-3' (reverse); for IFN-beta, 5'-ACACAAGCTTAACCACCATGAACAACAGGTGGATCCTCCACGC-3' (forward) and 5'-GTTAGGAATTCTCAGTTTTGGAAGTTTCTGGTAAGTCTTCG-3' (reverse); and for HPRT, 5'-CAAGCTTGCTGGTGAAAAGGA-3' (forward) and 5'-TGAAGTACTCATTATAGTCAAGGGCATATC-3' (reverse). Standard curves for IFN-{alpha}2, IFN-beta, and HPRT were established using serial dilutions of template cDNA in triplicate in the RelQuant software (Roche Applied Science). Levels of IFN-{alpha}2, IFN-beta, and HPRT mRNA were calculated based on these established standard curves, and the amounts of IFN-{alpha}2 and IFN-beta mRNA were normalized to the amount of HPRT in each sample. All samples were analyzed in triplicate.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Delayed H Chain Disulfide Bond Formation Is Observed upon Depletion of ERp57 but Not ERp72—To study the function of ERp57 in the process of class I biogenesis, we reduced the expression of ERp57 in L cells expressing the class I H-2Kb molecule by transfecting with 21-bp siRNAs. Following a 4-day transfection with siRNA 1, greater than 90% of ERp57 was depleted (Fig. 1A). No expression differences were observed for several other proteins, including CNX or the thiol oxidoreductases ERp72, PDI, and CaBP1. As a control to assess the effect of reducing the expression of a thiol oxidoreductase not previously implicated in class I biogenesis, we performed a similar experiment using siRNA directed against ERp72. Again, the level of ERp72 was reduced by >90% with no effects on the expression of ERp57 or several other proteins (Fig. 1B).


Figure 1
View larger version (54K):
[in this window]
[in a new window]
 
FIGURE 1.
Silencing effect of RNA interference on ERp57 and ERp72 expression. Kb-transfected L cells (1 x 105/well in a 6-well plate) were transfected with 40 nM siRNA targeting ERp57 (A) or ERp72 (B) mRNA or the same concentration of a control siRNA that is known not to affect the expression of mammalian proteins. After 4 days of transfection, cells were lysed, and equal amounts of cell lysate were subjected to SDS-PAGE and immunoblotted with the indicated antibodies.

 
Based on previous studies suggesting an interaction of ERp57 with free class I H chains (8, 27), we anticipated that this enzyme might participate in H chain disulfide formation. Consequently, the effect of ERp57 depletion on H chain disulfide bond formation was monitored in a pulse-chase experiment. After transfecting with ERp57 siRNA 1 or with control siRNA, L cells expressing the class I H-2Kb molecule were radiolabeled for 2 min with [35S]Met and chased in medium containing unlabeled Met and cycloheximide for periods of up to 30 min. Kb molecules were recovered from cell lysates with anti-8, an antiserum that reacts with free or beta2m-associated Kb H chains. Isolated Kb H chains were analyzed by SDS-PAGE under nonreducing conditions to allow resolution of species containing zero, one, or two disulfide bonds. The results show that disulfide bond formation was substantially slowed in the absence of ERp57 (Fig. 2A, top; quantified in Fig. 2B, siRNA 1). In control cells, 50% of H chains acquired both disulfide bonds by ~2 min of chase, whereas in ERp57-depleted cells, the rate was 9-fold slower, with 50% of H chains acquiring both disulfide bonds by 18 min of chase. In this experiment, no zero-disulfide bond species was detected, possibly because the first disulfide bond formed co-translationally and therefore was already present following the 2-min pulse. To confirm these results, the same experiment was performed using siRNA 2, which targets a different region of the ERp57 mRNA (Fig. 2A, middle). In this case, the rate of H chain disulfide formation was slowed 11-fold upon depletion of ERp57 (quantified in Fig. 2B, siRNA 2). The half-time for acquisition of both disulfide bonds was ~2 min in control cells versus 22 min in ERp57-depleted cells. In experiments testing the effect of ERp57 siRNA 2 on various control proteins, it was noted that this siRNA caused a ~50% reduction of ERp72 expression in addition to the depletion of ERp57 (data not shown). However, this "off-target" depletion of ERp72 by siRNA 2 did not contribute to the observed slower H chain oxidation, since knockdown of ERp72 expression alone by >90% had no significant effect on H chain oxidation (Fig. 2A, bottom; quantified in Fig. 2B). The lack of effect due to ERp72 depletion, coupled with previous studies showing a lack of PDI interaction during class I biogenesis (26), suggests that ERp57 may be the preferred thiol oxidoreductase promoting oxidative class I H chain folding.

ERp57 Is Required for {alpha}3 Domain Folding but Not for H Chain-beta2m Association—As an independent means to assess the involvement of ERp57 in H chain disulfide formation, the folding rate of the H chain {alpha}3 domain of class I H-2Dd molecules was assessed using mAb 34-2-12S. This antibody only recognizes Dd molecules that have a folded {alpha}3 domain with an intact disulfide bond (17). In this experiment, L cells expressing D molecules were transfected with ERp57 siRNA 1 or control siRNA and subjected to pulse-chase radiolabeling, and cell lysates were immunoisolated with mAb 34-2-12S. In contrast to cells treated with control siRNA, the {alpha}3 domain epitope formed more slowly when ERp57 expression was reduced by RNA interference (Fig. 3A, top). Whereas the t1/2 for epitope formation was ~2 min in control cells, it was 8-fold slower in ERp57-depleted cells (t1/2 siRNA 1 = 16 min) (Fig. 3B). This finding was confirmed using ERp57 siRNA 2, for which a 9-fold slower rate of epitope formation was observed relative to control cells (Fig. 3A, middle; quantified in Fig. 3B). The observed slower {alpha}3 domain folding was not due to simultaneous partial depletion of ERp72 by siRNA 2, since ERp72 depletion alone had no effect (Fig. 3A, bottom).


Figure 2
View larger version (38K):
[in this window]
[in a new window]
 
FIGURE 2.
Class I H chain disulfide bond formation is slowed upon depletion of ERp57. A, kinetics of disulfide bond formation. After reducing ERp57 or ERp72 expression with the indicated siRNAs, L cells expressing Kb molecules were radiolabeled with [35S]Met for 2 min and chased with unlabeled medium containing cycloheximide for various periods. Cells were washed with PBS containing 20 mM NEM and lysed in 1% Nonidet P-40 lysis buffer containing NEM. Kb H chain was recovered with anti-8 antibody and analyzed by nonreducing SDS-PAGE. The designations ERp57 + or – refer to cells expressing ERp57 (control siRNA) or lacking ERp57 (siRNA 1 or 2), respectively. Species of H chain containing different numbers of disulfide bonds are indicated by 0, 1, and 2 S–S. The sample in the left lane was treated with dithiothreitol (DTT) to provide a mobility standard of reduced Kb H chain. The extent of target protein knockdown in each experiment was as follows: ERp57 siRNA 1, 97%; ERp57 siRNA 2, 92%; and ERp72 siRNA, 96%. Each panel is representative of three independent experiments. B, quantification of fully oxidized H chain in A. Using NIH Image software, boxes were drawn to enclose bands corresponding to singly and doubly disulfide-bonded H chains. Boxes of equal size were drawn around segments of gel lanes that lacked bands to serve as background controls. Following background subtraction, the fully oxidized H chain was calculated as a percentage of the total H chain signal (single plus fully disulfide-bonded species) at each time point. Similar rates were observed in three independent experiments.

 
In contrast to H chain disulfide formation, all efforts to detect effects of ERp57 depletion on the kinetics of H chain-beta2m association were unsuccessful. As shown in Fig. 4A (top), isolation of beta2m-associated Dd H chains with mAb 34-5-8s at various times during a pulse-chase experiment showed no differences in either the kinetics or extent of H chain-beta2m formation in the absence or presence of ERp57. Similar results were obtained for Kb using mAb 20-8-4S, which reacts only with beta2m-associated Kb molecules (Fig. 4A, bottom). The finding that H chain-beta2m association kinetics were unaltered in the absence of ERp57 despite slower {alpha}3 domain folding indicates that heterodimer formation does not require an intact disulfide bond within the {alpha}3 domain.

The Peptide Loading Complex Assembles Properly upon Depletion of ERp57—Cresswell and co-workers (29) have demonstrated that ERp57 is disulfide-linked to tapasin within the peptide loading complex. Consequently, it was of interest to determine whether the peptide loading complex can assemble in the absence of ERp57. To test this, cells transfected with control or ERp57 siRNA were radiolabeled for 45 min and lysed in the mild detergent, digitonin, which preserves the integrity of the peptide loading complex. Anti-tapasin antibody was then used to immunoisolate the complex. As shown in Fig. 5A (left), all components of this protein complex were identified in cells transfected with control siRNA: TAP1, TAP2, CRT, ERp57, tapasin, H chain, and beta2m. Under nonreducing conditions (Fig. 5A, right), several components, including CRT, ERp57, and H chain, migrated faster due to the presence of intramolecular disulfide bonds. Also, under nonreducing conditions, the complex containing ERp57 disulfide linked to tapasin could be detected at ~110 kDa. Upon ERp57 depletion, the ERp57 band (Fig. 5A, left) was absent as expected, whereas the tapasin-ERp57 band (Fig. 5A, right panel) appeared diminished rather than absent. However, a number of faint background bands were present in the tapasin-ERp57 region of the gel, making it difficult to identify this species conclusively following ERp57 knockdown. To address this issue, lysates of control and ERp57-depleted cells were subjected to nonreducing SDS-PAGE and immunoblotted with anti-tapasin or anti-ERp57 Ab. As shown in Fig. 5B, ERp57 depletion reduced the amount of tapasin-ERp57 complex by 70% as detected with anti-ERp57 Ab and by 90% as detected with anti-tapasin Ab. Despite this extensive loss of the tapasin-ERp57 complex, all other components of the peptide loading complex remained fully associated (Fig. 5A, both panels). Although we cannot exclude the possibility that the low level of residual ERp57 might be sufficient to maintain full assembly of the peptide loading complex, it seems more likely that the loading complex is able to assemble normally without ERp57. It is noteworthy that there was no apparent change in the oxidation state of the H chain in the presence or absence of ERp57 (Fig. 5A, compare H chain mobilities in nonreducing lanes). It has been shown previously that when the disulfide cross-link between ERp57 and tapasin is prevented through mutation of Cys95 in tapasin, H chain oxidation is impaired (29).


Figure 3
View larger version (46K):
[in this window]
[in a new window]
 
FIGURE 3.
Impaired Dd {alpha}3 domain folding upon reducing ERp57 expression. A, kinetics of Dd {alpha}3 domain folding examined by pulse-chase radiolabeling. After reducing ERp57 or ERp72 expression with the indicated siRNAs, L cells expressing Dd molecules were radiolabeled with [35S]Met for 2 min and chased with unlabeled medium containing cycloheximide for various periods. Cells were washed and lysed in NEM-containing buffer, and Dd H chains with a disulfide-bonded {alpha}3 domain were recovered with mAb 34-2-12S and analyzed by reducing SDS-PAGE. In the bottom portions of each panel, equal aliquots of cell lysates were immunoblotted with anti-actin antiserum to serve as a loading control. The extent of target protein knockdown in each experiment was as follows: ERp57 siRNA 1, 95%; ERp57 siRNA 2, 93%; and ERp72 siRNA, 92%. Each panel is representative of two independent experiments. B, quantification of Dd H chains in A. As quantified by densitometry, the amount of Dd H chain with a disulfide-linked {alpha}3 domain is presented as a percentage of the maximum H chain signal. Values are normalized to the amount of actin in each sample to control for variations in sample loading.

 


Figure 4
View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 4.
The kinetics of H chain-beta2m association upon reducing ERp57 expression. A, the kinetics of beta2m association with Dd and Kb H chains were examined by pulse-chase radiolabeling. After transfection with control siRNA (+ERp57) or ERp57 siRNA (–ERp57), L cells expressing Dd or Kb molecules were radiolabeled with [35S]Met for 2 min and chased with unlabeled medium containing cycloheximide for various periods. Cells were washed and lysed in NEM-containing buffer, beta2m-associated Dd molecules were recovered with mAb 34-5-8S antibody, and beta2m-associated Kb molecules were recovered with mAb 20-8-4S. Immune complexes were analyzed by reducing SDS-PAGE. Note that the conversion of Kb H chains to a higher molecular weight species at the 30- and 60-min time points represents processing of Asn-linked glycans to complex forms in the Golgi. B, quantification of beta2m-associated Dd and KbH chains in A. As quantified by densitometry, the amount of beta2m-associated H chain is presented as a percentage of the maximum H chain signal.

 


Figure 5
View larger version (33K):
[in this window]
[in a new window]
 
FIGURE 5.
Assembly of the peptide loading complex in the absence of ERp57. A, Kb-expressing L cells transfected with control siRNA (+ERp57) or ERp57 siRNA (–ERp57) were radiolabeled for 45 min with [35S]Met, washed with PBS containing 20 mM NEM, and lysed in 1% digitonin lysis buffer containing 20 mM NEM. The peptide loading complex was immunoisolated (I.B.) with anti-tapasin antiserum and analyzed by SDS-PAGE under reducing (left) and nonreducing (right) conditions. Components of the complex were identified by comparison with previous peptide loading complexes isolated in the laboratory in which the identities of proteins were confirmed by sequential immunoisolation (36). B, to examine the amounts of tapasin-ERp57 conjugate present in Kb-expressing L cells transfected with control or ERp57 siRNA, cell lysates were analyzed by SDS-PAGE under nonreducing conditions. Tapasin-ERp57 conjugate was detected by immunoblotting with antibodies against ERp57 or tapasin as indicated and quantified by densitometry.

 
Within the peptide loading complex, the interaction of MHC class I molecules with tapasin occurs via contacts through the H chain {alpha}2 and {alpha}3 domains (36, 37). Since we have shown that {alpha}3 domain folding is slowed in the absence of ERp57, we suspected that this might impede the association of H chain with tapasin. This hypothesis was tested by transfecting Kb -or Dd-expressing L cells with control or ERp57 siRNA and subjecting the transfectants to pulse-chase radiolabeling. Cells were lysed in digitonin lysis buffer, and class I-tapasin complexes were recovered with anti-tapasin antibody. Analysis of the complexes by nonreducing SDS-PAGE revealed no significant difference in the kinetics of tapasin association with Kb or Dd in the presence and absence of ERp57 (data not shown). Therefore, the slower {alpha}3 domain folding that occurs upon ERp57 depletion does not significantly impede the association of H chains with tapasin.

Class I ER to Golgi Transport Is Slightly Delayed upon ERp57 Depletion—Since incompletely folded molecules are typically retained in the ER, it was of interest to determine whether the slower oxidative folding of H chains observed in ERp57-depleted cells is also manifested in their intracellular transport kinetics. Intracellular transport of Kb molecules in the presence or absence of ERp57 was monitored in a pulse-chase experiment followed by endo H digestion. As shown in Fig. 6, slower transport of the Kb molecule was detected upon ERp57 depletion, as indicated by a slower rate of formation of endo H-resistant molecules. The extent of the reduction in transport rate varied slightly between experiments, as illustrated in the top and middle of Fig. 6A. In experiment 1, the half-times for acquisition of endo H resistance were 26 min in the presence of ERp57 and 44 min in its absence. In experiment 2, these values were 25 and 35 min, respectively (Fig. 6B). The less substantial difference depicted in experiment 2 was more typical for Kb (n = 4 experiments; p < 0.02) For the H-2Dd molecule, the t1/2 value for acquisition of endo H resistance also increased from 59 to 80 min in the presence and absence of ERp57, respectively (Fig. 6, A (bottom) and B; n = 2 experiments; p < 0.05). We conclude that in the absence of ERp57, the ER to Golgi transport of H-2Kb and Dd molecules is slightly impeded.

More Class I Molecules Are Present on the Cell Surface upon Reduction of ERp57, but Peptide Loading Is Unaffected—Previous studies have shown that when the ERp57-tapasin disulfide cross-link is prevented by mutation of tapasin, peptide loading of class I molecules may either be impaired (29) or unaltered (38), depending on the class I molecule examined. To determine if peptide loading is affected upon ERp57 depletion, we first examined the cell surface expression of class I molecules, since loading defects are often accompanied by reduced levels of class I molecules at the cell surface. Surprisingly, the steady state levels of Kb and Dd molecules at the cell surface were about 20% higher when ERp57 was depleted by siRNA treatment compared with control siRNA-treated cells (Fig. 7A).

The thermal stability of a class I molecule is proportional to the affinity of peptides bound within its binding groove and as such provides a readout of the quality and extent of peptides loaded. We compared the thermal stabilities of cell surface Kb and Dd in the presence or absence of ERp57. This was done by first incubating cells overnight at 26 °C in the presence of exogenous beta2m to stabilize any class I molecules arriving at the cell surface that are empty or possess low affinity peptides. The temperature was then shifted to 37 °C in the presence of brefeldin A to block any new class I transport to the cell surface, and then surface class I levels were measured by flow cytometry using conformation-sensitive mAbs. As shown in Fig. 7B, Kb and Dd molecules exhibited similar thermal stabilities in the absence or presence of ERp57.

We also examined the extent to which Kb molecules are loaded with the ovalbumin-derived peptide SIINFEKL and presented at the cell surface. EL4 cells expressing a truncated form of ovalbumin were transfected with control or ERp57 siRNA and assessed for cell surface Kb-SIINFEKL complexes using mAb 25-D1-16. Following normalization for the differences in Kb expression, the SIINFEKL peptide was presented just as effectively in the absence of ERp57 as in its presence (Fig. 7E). This finding is consistent with the unaltered cell surface stabilities of Kb and Dd molecules and suggests that peptide loading is unaffected by depletion of ERp57.

To address the question of whether the up-regulation of class I molecules on the cell surface was due to the depletion of ERp57 or simply a side effect of siRNA treatment, cells were transfected with a variety of siRNAs possessing different target specificities, and then surface class I levels were measured (Fig. 7C). Of the siRNAs tested, those that targeted ERp57, ERp72, and septin 3 were capable of boosting class I cell surface levels, but caveolin and septin 5 siRNAs were not. The ability of septin 3 siRNA to up-regulate class I expression was particularly informative. Septin 3 is a member of the septin subfamily of GTPase domain proteins and, being human neuronal cell-specific, is not expressed in mouse L cells. It is also not expected to be involved in any aspect of class I homeostasis. This suggests that the up-regulation of class I is a side effect of the siRNA transfection. Further support for this view comes from the finding that the class I up-regulation increased with increasing siRNA concentration (Fig. 7C, ERp72 siRNA). Both 40 and 80 nM ERp72 siRNA depleted ERp72 to similar extents (data not shown), yet class I surface levels continued to increase at the higher concentration (Fig. 7C).


Figure 6
View larger version (45K):
[in this window]
[in a new window]
 
FIGURE 6.
Class I transport is slightly slowed in the absence of ERp57. A, Kb- or Dd-expressing L cells transfected with control siRNA (+ERp57) or ERp57 siRNA (–ERp57) were radiolabeled with [35S]Met for 2 min and chased with unlabeled medium for various periods. Following lysis in Nonidet P-40 lysis buffer, Kb and Dd molecules were immunoisolated with anti-8 antiserum or mAb 34-2-12S, respectively. Immune complexes were digested with endo H and analyzed by SDS-PAGE under reducing conditions. Two independent experiments are shown for H-2Kb and a single representative experiment for Dd. The endo H-sensitive (endo Hs) and endo H-resistant (endo Hr) H chain species are labeled. A protein recovered nonspecifically in immune isolates is indicated by the asterisk. B, quantification of the data depicted in A. The amount of endo H-resistant H chain was quantified by densitometry and is expressed as a percentage of the total H chains recovered at each time point. Due to a contaminating band in the region of endo H-resistant H chain at the 0 min time point of experiment 1 (expt.1), quantification at this time point was not performed.

 
It has been reported that the interferon system may be activated by short interfering RNAs (3941) and that the activation may depend on the siRNA sequence used (40, 42). We suspected that some of the siRNAs used in this study have the intrinsic ability to elevate IFN levels and thereby increase class I surface expression. For this reason, the mRNA levels of IFN-{alpha}2 and IFN-beta were measured using quantitative reverse transcription-PCR. Compared with untransfected cells, the level of IFN-{alpha}2 mRNA was unaltered upon transfection with control siRNA, whereas transfection with ERp57 siRNA increased the IFN-{alpha}2 mRNA level by 10-fold, and ERp72 siRNA increased IFN-{alpha}2 mRNA by 168-fold (Fig. 7D). The IFN-beta mRNA level remained unchanged in the four samples (data not shown). These observations reinforce the conclusion that the up-regulation of cell surface class I is a side effect of siRNA transfection, not the direct effect of removing a particular protein. Also, it is important to stress that the observed slower oxidative folding of class I molecules (Figs. 2 and 3) is due to the lack of ERp57 and not due to elevated IFN expression. This is based on the fact that ERp72 knockdown dramatically increased IFN-{alpha}2 expression as well as up-regulated surface class I (Fig. 7, C and D) but had no effect on the rate of oxidative class I folding (Figs. 2 and 3).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Despite observations that ERp57 catalyzes disulfide bond formation in vitro (10) and associates with a variety of newly synthesized glycoproteins, including MHC class I molecules (14, 26, 27, 43, 44), direct demonstrations of its in vivo functions have remained elusive. To address this issue, we examined disulfide formation in the class I H-2Kb H chain in vivo in the presence and absence of ERp57. In the presence of ERp57, the first of the two H chain disulfides formed very rapidly within the 2-min pulse labeling period, whereas the second disulfide formed more slowly, requiring more than 6 min for completion in all radiolabeled H chains. Using RNA interference to deplete the expression of ERp57 to less than 10% of its normal level, we show that this enzyme does indeed promote disulfide bond formation and domain folding of the class I H chain in vivo. Specifically, little effect of ERp57 depletion was observed upon the rapid formation of the first disulfide bond, but the rate of formation of the second disulfide was slowed by ~10-fold. This was confirmed by demonstrating that the rate of oxidative folding of the {alpha}3 domain in the closely related H-2Dd molecule, defined by mAb 34-2-12S reactivity, was similarly slowed. Surprisingly, the kinetics of H chain-beta2m association were unaltered upon ERp57 depletion. This indicates that beta2m, which makes contacts with residues in the {alpha}1, {alpha}2, and {alpha}3 domains (45), is capable of associating with H chains before a native {alpha}3 conformation has been achieved. This is in line with previous reports suggesting that beta2m association may actually enhance the formation of the second H chain disulfide (18).


Figure 7
View larger version (26K):
[in this window]
[in a new window]
 
FIGURE 7.
Cell surface expression and stability of MHC class I molecules in the presence or absence of ERp57. A, cell surface expression of Kb and Dd molecules. Kb- or Dd-expressing L cells were transfected with ERp57 siRNA (–ERp57) or control siRNA (+ERp57). Four days later, cells were incubated with mAb Y3 to detect beta2m-associated Kb molecules or mAb 34-5-8S to detect beta2m-associated Dd molecules followed by incubation with phycoerythrin-labeled goat anti-mouse IgG. Samples were then analyzed by flow cytometry. The negative control was stained with secondary antibody only. The mean fluorescence values are plotted as percentages relative to cells transfected with control siRNA. The error bars represent the S.E. values of three independent experiments. B, stability of cell surface Kb and Dd molecules. Kb- or Dd-expressing L cells were transfected with ERp57 siRNA (–ERp57) or control siRNA (+ERp57) for 4 days and incubated at 26 °C in the presence of exogenous human beta2m for 18 h prior to the end of the fourth day. Cells were then shifted to 37 °C, and brefeldin A (10 µg/ml) was added to prevent the surface appearance of new class I molecules. At the indicated times, cell surface Kb or Dd molecules were quantified by flow cytometry using mAb Y3 or 34-5-8S, respectively, followed by phycoerythrin-labeled goat anti-mouse IgG. Mean fluorescence values are plotted as a percentage relative to control cells at the 0-h time point. C, cell surface expression of Kb molecules following transfection with a variety of siRNAs. Kb-expressing L cells were transfected with the indicated siRNAs (40 nM), and 4 days later, surface Kb expression was measured by flow cytometry using mAb Y3. The error bars represent the S.E. values from duplicate experiments. D, INF-{alpha}2 mRNA levels following siRNA treatment. Kb-transfected L cells were transfected with the indicated siRNAs and harvested after 12 h. RNA was extracted from these cells, reverse transcribed, and subjected to quantitative PCR. ctrl, control. E, effect of ERp57 depletion on peptide presentation by Kb molecules. Mouse EL4 TO cells, expressing truncated ovalbumin, were transfected with 240 nM ERp57 siRNA or control siRNA using a Nucleofector device under parameter O17. Cells were maintained in RPMI 1640 in the presence of siRNA for 3 days, and Kb complexed with the ovalbumin peptide SIINFEKL was measured by flow cytometry using mAb 25-D1-16. The peptide loading efficiency was expressed as the Kb-SIINFEKL level divided by the surface Kb level (as detected with mAb Y3).

 
ERp57 is known to interact directly with both CNX and CRT (11, 46, 47), suggesting that these chaperones may recruit ERp57 to folding glycoproteins. This concept is supported by the finding that prevention of CNX and CRT interactions with glycoproteins, through treatment of cells with oligosaccharide processing inhibitors, often abrogates ERp57 interactions with glycoprotein substrates (14, 44). Furthermore, Zapun et al. (10) have shown that oxidative folding of monoglucosylated ribonuclease B by ERp57 in vitro is more efficient when either CNX or CRT are present. Consequently, we assessed the involvement of CNX and CRT in the ERp57-catalyzed oxidation of class I H chains by measuring the kinetics of H chain disulfide formation in CRT-deficient mouse cells and in L cells transfected with siRNA to deplete CNX. Surprisingly, in the absence of either chaperone, the activity of ERp57 was not compromised (i.e. no delayed disulfide bond formation was observed (data not shown)). These observations indicate that although it is widely thought that CNX and CRT determine ERp57 substrate specificity, it is not the case for MHC class I molecules. This finding is consistent with a recent report demonstrating that CNX and CRT are also not required for the formation of the tapasin-ERp57 disulfide-linked conjugate within the peptide loading complex (28).

If CNX and CRT do not function as carriers to bring ERp57 into the proximity of folding class I molecules, how does ERp57 gain access to H chains? Tapasin is unlikely to recruit ERp57 during early oxidative folding of the H chain, since it associates with class I molecules mainly within the peptide loading complex after disulfide bond formation is largely complete (Fig. 5). Therefore, we propose that ERp57 is capable of recognizing newly synthesized H chains directly, and this is one reason for its preferential involvement in early class I biogenesis over other thiol oxidoreductases, such as PDI (26). Presumably, these or other thiol oxidoreductases can function to some extent during class I folding when ERp57 is absent, since our findings demonstrate that ERp57 depletion slows but does not arrest H chain disulfide formation.

It has been demonstrated that as much as 80% of the cellular pool of ERp57 can exist as a mixed disulfide cross-linked to tapasin within the peptide loading complex (28). What then is the role that ERp57 plays within this complex? Previous studies have provided conflicting results. When formation of the ERp57-tapasin cross-link was prevented by mutagenesis of Cys95 of tapasin, partially oxidized human HLA-B44 H chains were detected in the loading complex, and peptide loading was compromised (29). However, in another study employing the same Cys95 mutation, no impairment of peptide loading was observed for mouse H-2Kb molecules (38). Consistent with the latter study, we found that ERp57 depletion did not alter entry of H-2Kb or H-2Dd H chains into the loading complex; nor was there any alteration in complex composition other than the loss of ERp57. Furthermore, ERp57 depletion did not give rise to partially oxidized H chains within the loading complex, and peptide loading appeared normal.

While this manuscript was under review, Garbi et al. (48) reported an examination of class I biogenesis in B cell blasts derived from mice with an ERp57-deficient B cell compartment. In contrast to our experiments, they observed that although class I H-2Kb molecules were recruited into the peptide loading complex, the loading complex was unstable. This had the effect of reducing surface expression of H-2Kb by about 50%, with an impairment in the loading of some, but not all, peptides tested. However, minimal effects of ERp57 depletion were observed on the surface expression or peptide content of H-2Db molecules. They further concluded that the redox state of class I molecules either within or outside the peptide loading complex was unaffected by the lack of ERp57 (48). Whereas this latter finding agrees with the lack of effect we observed of ERp57 depletion on the redox state of class I molecules within the loading complex, it contrasts sharply with our finding that ERp57 promotes early H chain disulfide formation.

The discrepancies between our work and that of Garbi et al. are most likely due to the different experimental approaches used. To assess class I redox state, Garbi et al. examined the entire cellular pool of H chains by immunoblotting, a pool that is dominated by mature H chains at the cell surface (48). In contrast, our pulse-chase approach permitted the analysis of a very small pool of class I H chains immediately after entry into the ER lumen, a technique capable of revealing differences in the folding kinetics of the H chain in the presence and absence of ERp57 (Figs. 2 and 3). It is less clear why our studies differed concerning the effect of ERp57 depletion on the stability of the H-2Kb-containing peptide loading complex and subsequent peptide loading and surface expression. One possibility is that the ~10–30% residual ERp57-tapasin complex remaining after siRNA treatment (Fig. 5B) is sufficient to maintain full assembly of Kb molecules within the peptide loading complex. We also cannot exclude the possibility that increases in IFN{alpha}2 following siRNA treatment might influence loading complex function by an unknown mechanism. Further studies using different cell types, different class I molecules, and different approaches will be required to clarify this issue, particularly in light of the variable results already observed with different class I molecules and species (29, 38, 48). Nevertheless, the collective results underscore the involvement of ERp57 both in the early oxidative folding of class I H chains and in maintaining the integrity of the loading complex.

Our findings raise interesting questions concerning the mechanisms governing the substrate specificities of the 17 PDI family members that exist within the mammalian ER (49). ERp57 is clearly the preferred family member engaged in class I biogenesis, and its substrate specificity seems to reside within ERp57 itself rather than through recruitment by either CNX or CRT (see above). Our depletion studies have suggested that the absence of ERp57 may be partially complemented during early stages of H chain folding and possibly fully complemented by other PDI family members at the level of the peptide loading complex. To what extent do these other family members normally participate in class I biogenesis? Of the 17 members identified thus far, only PDI, PDIp, ERp72, and ERp57 share similar characteristics, which include four thioredoxin-like domains (termed a, b, b', and a'); at least two -CGHC- or closely related active site sequences that permit oxidation, reduction, and isomerization reactions; a conserved arginine residue thought to modulate the pKa of the active site; conserved charged pair sequences that are involved in proton transfer reactions; and a b' domain that contains a high affinity substrate binding site (49). In this study, ERp72 was depleted by siRNA treatment, and no effect was observed on the oxidative folding of class I H chains or on subsequent assembly steps. Furthermore, when both ERp57 and ERp72 were depleted by an unexpected cross-targeting siRNA, the phenotype was indistinguishable from that of ERp57 depletion alone (Figs. 2 and 3). These observations reinforce the viewpoint that different thiol oxidoreductases are specific for a particular group of substrates (50, 51). It will be of considerable interest to extend our findings by depleting PDI and PDIp either alone or in combination with ERp57 and ERp72 to explore further their specificities and potential functional overlap in the biogenesis of the MHC class I molecule.

During final review of this manuscript, Molinari and co-workers (52) published a report demonstrating that ERp57-deficient fibroblasts exhibit impaired oxidative folding of influenza hemagglutinin but not of Semliki Forest virus glycoproteins, E1, and p62.


    FOOTNOTES
 
* This work was supported by the National Cancer Institute of Canada with funds from the Canadian Cancer Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 To whom correspondence should be addressed: Dept. of Biochemistry, Medical Sciences Bldg., University of Toronto, Toronto, Ontario M5S 1A8, Canada. Tel.: 416-978-2546; Fax: 416-978-8548; E-mail: david.williams{at}utoronto.ca.

2 The abbreviations used are: ER, endoplasmic reticulum; beta2m, beta2-microglobulin; CNX, calnexin; CRT, calreticulin; endo H, endoglycosidase H; siRNA, small interfering RNA; PDI, protein-disulfide isomerase; MHC, major histocompatibility complex; H chain, heavy chain; DMEM, Dulbecco's modified Eagle's medium; Ab, antibody; mAb, monoclonal antibody; PBS, phosphate-buffered saline; NEM, N-ethylmaleimide; IFN, interferon; HPRT, hypoxanthine-guanine phosphoribosyltransferase. Back


    ACKNOWLEDGMENTS
 
We thank Dr. William Trimble (Hospital for Sick Children, Toronto) for siRNAs targeting septins, Dr. Chi-Hung Siu (University of Toronto) for siRNA targeting caveolin, Dr. Nilabh Shastri (University of California Berkeley) for EL4 cells expressing truncated ovalbumin, and Dr. David Ferrari (Max-Planck Institute, Goettingen) for anti-CaBP1 antiserum. We also thank Dr. Eleanor Fish (Department of Immunology, University of Toronto) for helpful advice.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Bourdi, M., Demady, D., Martin, J. L., Jabbour, S. K., Martin, B. M., George, J. W., and Pohl, L. R. (1995) Arch. Biochem. Biophys. 323, 397–403[CrossRef][Medline] [Order article via Infotrieve]
  2. Hirano, N., Shibasaki, F., Sakai, R., Tanaka, T., Nishida, J., Yazaki, Y., Takenawa, T., and Hirai, H. (1995) Eur. J. Biochem. 234, 336–342[Medline] [Order article via Infotrieve]
  3. Koivunen, P., Helaakoski, T., Annunen, P., Veijola, J., Raisanen, S., Pihlajaniemi, T., and Kivirikko, K. I. (1996) Biochem. J. 316, 599–605[Medline] [Order article via Infotrieve]
  4. Alanen, H. I., Salo, K. E., Pekkala, M., Siekkinen, H. M., Pirneskoski, A., and Ruddock, L. W. (2003) Antioxid. Redox Signal. 5, 367–374[CrossRef][Medline] [Order article via Infotrieve]
  5. Silvennoinen, L., Myllyharju, J., Ruoppolo, M., Orru, S., Caterino, M., Kivirikko, K. I., and Koivunen, P. (2004) J. Biol. Chem. 279, 13607–13615[Abstract/Free Full Text]
  6. Frand, A. R., Cuozzo, J. W., and Kaiser, C. A. (2000) Trends Cell Biol. 10, 203–210[CrossRef][Medline] [Order article via Infotrieve]
  7. Noiva, R. (1999) Semin. Cell Dev. Biol. 10, 481–493[CrossRef][Medline] [Order article via Infotrieve]
  8. Antoniou, A. N., Ford, S., Alphey, M., Osborne, A., Elliott, T., and Powis, S. J. (2002) EMBO J. 21, 2655–2663[CrossRef][Medline] [Order article via Infotrieve]
  9. Frickel, E. M., Frei, P., Bouvier, M., Stafford, W. F., Helenius, A., Glockshuber, R., and Ellgaard, L. (2004) J. Biol. Chem. 279, 18277–18287[Abstract/Free Full Text]
  10. Zapun, A., Darby, N. J., Tessier, D. C., Michalak, M., Bergeron, J. J., and Thomas, D. Y. (1998) J. Biol. Chem. 273, 6009–6012[Abstract/Free Full Text]
  11. Frickel, E. M., Riek, R., Jelesarov, I., Helenius, A., Wuthrich, K., and Ellgaard, L. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 1954–1959[Abstract/Free Full Text]
  12. Spiro, R. G., Zhu, Q., Bhoyroo, V., and Soling, H. D. (1996) J. Biol. Chem. 271, 11588–11594[Abstract/Free Full Text]
  13. Ware, F. E., Vassilakos, A., Peterson, P. A., Jackson, M. R., Lehrman, M. A., and Williams, D. B. (1995) J. Biol. Chem. 270, 4697–4704[Abstract/Free Full Text]
  14. Molinari, M., and Helenius, A. (1999) Nature 402, 90–93[CrossRef][Medline] [Order article via Infotrieve]
  15. Paulsson, K., and Wang, P. (2003) Biochim. Biophys. Acta 1641, 1–12[Medline] [Order article via Infotrieve]
  16. Lehner, P. J., and Cresswell, P. (2004) Curr. Opin. Immunol. 16, 82–89[CrossRef][Medline] [Order article via Infotrieve]
  17. Ribaudo, R. K., and Margulies, D. H. (1992) J. Immunol. 149, 2935–2944[Abstract]
  18. Wang, H., Capps, G. G., Robinson, B. E., and Zuniga, M. C. (1994) J. Biol. Chem. 269, 22276–22281[Abstract/Free Full Text]
  19. Miyazaki, J., Appella, E., and Ozato, K. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 757–761[Abstract/Free Full Text]
  20. Warburton, R. J., Matsui, M., Rowland-Jones, S. L., Gammon, M. C., Katzenstein, G. E., Wei, T., Edidin, M., Zweerink, H. J., McMichael, A. J., and Frelinger, J. A. (1994) Hum. Immunol. 39, 261–271[CrossRef][Medline] [Order article via Infotrieve]
  21. Ortmann, B., Androlewicz, M. J., and Cresswell, P. (1994) Nature 368, 864–867[CrossRef][Medline] [Order article via Infotrieve]
  22. Suh, W. K., Cohen-Doyle, M. F., Fruh, K., Wang, K., Peterson, P. A., and Williams, D. B. (1994) Science 264, 1322–1326[Abstract/Free Full Text]
  23. Momburg, F., and Tan, P. (2002) Mol. Immunol. 39, 217–233[CrossRef][Medline] [Order article via Infotrieve]
  24. Ortmann, B., Copeman, J., Lehner, P. J., Sadasivan, B., Herberg, J. A., Grandea, A. G., Riddell, S. R., Tampe, R., Spies, T., Trowsdale, J., and Cresswell, P. (1997) Science 277, 1306–1309[Abstract/Free Full Text]
  25. Paquet, M. E., Cohen-Doyle, M., Shore, G. C., and Williams, D. B. (2004) J. Immunol. 172, 7548–7555[Abstract/Free Full Text]
  26. Farmery, M. R., Allen, S., Allen, A. J., and Bulleid, N. J. (2000) J. Biol. Chem. 275, 14933–14938[Abstract/Free Full Text]
  27. Lindquist, J. A., Hammerling, G. J., and Trowsdale, J. (2001) FASEB J. 15, 1448–1450[Free Full Text]
  28. Peaper, D. R., Wearsch, P. A., and Cresswell, P. (2005) EMBO J. 24, 3613–3623[CrossRef][Medline] [Order article via Infotrieve]
  29. Dick, T. P., Bangia, N., Peaper, D. R., and Cresswell, P. (2002) Immunity 16, 87–98[CrossRef][Medline] [Order article via Infotrieve]
  30. Smith, M. H., Parker, J. M., Hodges, R. S., and Barber, B. H. (1986) Mol. Immunol. 23, 1077–1092[CrossRef][Medline] [Order article via Infotrieve]
  31. Ozato, K., Mayer, N. M., and Sachs, D. H. (1982) Transplantation 34, 113–120[Medline] [Order article via Infotrieve]
  32. Ozato, K., and Sachs, D. H. (1981) J. Immunol. 126, 317–321[Abstract]
  33. Jones, B., and Janeway, C. A., Jr. (1981) Nature 292, 547–549[CrossRef][Medline] [Order article via Infotrieve]
  34. Porgador, A., Yewdell, J. W., Deng, Y., Bennink, J. R., and Germain, R. N. (1997) Immunity 6, 715–726[CrossRef][Medline] [Order article via Infotrieve]
  35. Danilczyk, U. G., and Williams, D. B. (2001) J. Biol. Chem. 276, 25532–25540[Abstract/Free Full Text]
  36. Suh, W. K., Derby, M. A., Cohen-Doyle, M. F., Schoenhals, G. J., Fruh, K., Berzofsky, J. A., and Williams, D. B. (1999) J. Immunol. 162, 1530–1540[Abstract/Free Full Text]
  37. Paquet, M. E., and Williams, D. B. (2002) Int. Immunol. 14, 347–358[Abstract/Free Full Text]
  38. Howarth, M., Williams, A., Tolstrup, A. B., and Elliott, T. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 11737–11742[Abstract/Free Full Text]
  39. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A. L., and Iggo, R. (2003) Nat. Genet. 34, 263–264